Development of a Safeguard System Using an Episomal Mammalian Artificial Chromosome for Gene and Cell Therapy
The development of a safeguard system to remove tumorigenic cells would allow safer clinical applications of stem cells for the treatment of patients with an intractable disease including genetic disorders. Such safeguard systems should not disrupt the host genome and should have long-term stability...
Main Authors: | Narumi Uno, Katsuhiro Uno, Shinya Komoto, Teruhiko Suzuki, Masaharu Hiratsuka, Mitsuhiko Osaki, Yasuhiro Kazuki, Mitsuo Oshimura |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2015-01-01
|
Series: | Molecular Therapy: Nucleic Acids |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2162253116300580 |
Similar Items
-
Tracking Progress towards the International Safeguards for Children in Sport
by: Amy Lorraine Wilson, et al.
Published: (2022-07-01) -
Fluorescent tagged episomals for stoichiometric induced pluripotent stem cell reprogramming
by: Christopher E. Schmitt, et al.
Published: (2017-06-01) -
Amenable epigenetic traits of dental pulp stem cells underlie high capability of xeno-free episomal reprogramming
by: Srijaya Thekkeparambil Chandrabose, et al.
Published: (2018-03-01) -
TINDAKAN SAFEGUARD DALAM PASAR BEBAS ASEAN SEBAGAI UPAYA PERLINDUNGAN INDUSTRI DALAM NEGERI
by: Theresia L Pesulima
Published: (2017-06-01) -
HARMONISASI REGULASI DAN EFEKTIVITAS KELEMBAGAAN SAFEGUARD DI INDONESIA
by: Abdurrahman Alfaqiih
Published: (2012-06-01)